{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:36:32Z","timestamp":1777530992566,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12094-016-1517-x","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T10:51:02Z","timestamp":1463568662000},"page":"173-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience"],"prefix":"10.1007","volume":"19","author":[{"given":"E.","family":"Kempf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Desamericq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vieites","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Diaz-Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garcia-Arreza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Martinez-Maestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"issue":"2","key":"1517_CR1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2005.02.007","volume":"97","author":"JT Quirk","year":"2005","unstructured":"Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992\u20131999. Gynecol Oncol. 2005;97(2):519\u201323.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1517_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19990507)84:1<43::AID-AJMG9>3.0.CO;2-2","volume":"84","author":"AR Stettner","year":"1999","unstructured":"Stettner AR, Hartenbach EM, Schink JC, Huddart R, Becker J, Pauli R, et al. Familial ovarian germ cell cancer: report and review. Am J Med Genet. 1999;84(1):43\u20136.","journal-title":"Am J Med Genet"},{"issue":"1","key":"1517_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canep.2009.04.015","volume":"33","author":"C Giambartolomei","year":"2009","unstructured":"Giambartolomei C, Mueller CM, Greene MH, Korde LA. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiol. 2009;33(1):31\u20136.","journal-title":"Cancer Epidemiol."},{"issue":"7","key":"1517_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1586\/14737140.2013.811174","volume":"13","author":"E Nieuwenhuysen Van","year":"2013","unstructured":"Van Nieuwenhuysen E, Lambrechts S, Lambrechts D, Leunen K, Amant F, Vergote I. Genetic changes in nonepithelial ovarian cancer. Expert Rev Anticancer Ther. 2013;13(7):871\u201382.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"1517_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/er.2012-1045","volume":"34","author":"SM Kraggerud","year":"2013","unstructured":"Kraggerud SM, Hoei-Hansen CE, Alagaratnam S, Skotheim RI, Abeler VM, Rajpert-De Meyts E, et al. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev. 2013;34(3):339\u201376.","journal-title":"Endocr Rev"},{"issue":"2","key":"1517_CR6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-10-0857","volume":"20","author":"T Chen","year":"2011","unstructured":"Chen T, Surcel HM, Lundin E. Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer. Cancer Epidemiol Biomark Prev. 2011;20(2):324\u201336.","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"6","key":"1517_CR7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1525-1438.2003.13604.x","volume":"13","author":"LM Sanchez-Zamorano","year":"2003","unstructured":"Sanchez-Zamorano LM, Salazar-Martinez E, De Los Rios PE, Gonzalez-Lira G, Flores-Luna L, Lazcano-Ponce EC. Factors associated with non-epithelial ovarian cancer among Mexican women: a matched case-control study. Int J Gynecol Cancer. 2003;13(6):756\u201363.","journal-title":"Int J Gynecol Cancer."},{"issue":"5","key":"1517_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/bjc.1997.136","volume":"75","author":"G Albrektsen","year":"1997","unstructured":"Albrektsen G, Heuch I, Kv\u00e5le G. Full-term pregnancies and incidence of ovarian cancer of stromal and germ cell origin: a Norwegian prospective study. Br J Cancer. 1997;75(5):767\u201370.","journal-title":"Br J Cancer"},{"issue":"5","key":"1517_CR9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","volume":"107","author":"HO Smith","year":"2006","unstructured":"Smith HO, Berwick M, Verschraegen CF. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075\u201385.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1517_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1991.180","volume":"63","author":"I dos Santos Silva","year":"1991","unstructured":"dos Santos Silva I, Swerdlow AJ. Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer. Br J Cancer. 1991;63(5):814\u20138.","journal-title":"Br J Cancer"},{"issue":"6","key":"1517_CR11","first-page":"621","volume":"35","author":"A Ugianskiene","year":"2014","unstructured":"Ugianskiene A, Grove A, Soegaard-Andersen E. Adult granulosa cell tumor of the ovary: a retrospective study of 37 cases. Eur J Gynaecol Oncol. 2014;35(6):621\u20134.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"1517_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/IGC.0000000000000077","volume":"24","author":"HS Meurs van","year":"2014","unstructured":"van Meurs HS, Buist MR, Westermann AM, Sonke GS, Kenter GG, van der Velden J. Effectiveness of chemotherapy in measurable granulosa cell tumors: a retrospective study and review of literature. Int J Gynecol Cancer. 2014;24(3):496\u2013505.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"1517_CR13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1200\/JCO.2003.10.019","volume":"21","author":"ST Schumer","year":"2003","unstructured":"Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180\u20139 (Review).","journal-title":"J Clin Oncol."},{"issue":"17","key":"1517_CR14","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2004.12.074","volume":"22","author":"J Brown","year":"2004","unstructured":"Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004;22(17):3517\u201323.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1517_CR15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygyno.2006.06.022","volume":"103","author":"SA Freeman","year":"2006","unstructured":"Freeman SA, Modesitt SC. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases. Gynecol Oncol. 2006;103(2):755\u20138.","journal-title":"Gynecol Oncol"},{"issue":"17","key":"1517_CR16","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1200\/JCO.2004.01.006","volume":"22","author":"PC Rogers","year":"2004","unstructured":"Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, et al. Pediatric Oncology Group 9048; Children\u2019s Cancer Group 8891. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study\u2014Pediatric Oncology Group 9048 and Children\u2019s Cancer Group 8891. J Clin Oncol. 2004;22(17):3563\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1517_CR17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2001.19.4.1015","volume":"19","author":"G Zanetta","year":"2001","unstructured":"Zanetta G, Bonazzi C, Cant\u00f9 M, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001;19(4):1015\u201320.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1517_CR18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2013.51.1006","volume":"32","author":"DF Billmire","year":"2014","unstructured":"Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children\u2019s Oncology Group. J Clin Oncol. 2014;32(5):465\u201370.","journal-title":"J Clin Oncol"},{"issue":"30","key":"1517_CR19","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1200\/JCO.2006.06.2489","volume":"24","author":"N Murugaesu","year":"2006","unstructured":"Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I, et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol. 2006;24(30):4862\u20136.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1517_CR20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J. FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 2014;133(3):401\u20134.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1517_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","volume":"21","author":"GJ Rustin","year":"2011","unstructured":"Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, et al. Gynecological Cancer Intergroup. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011;21(2):419\u201323.","journal-title":"Int J Gynecol Cancer"},{"key":"1517_CR22","doi-asserted-by":"crossref","first-page":"vii20","DOI":"10.1093\/annonc\/mds223","volume":"Suppl7","author":"N Colombo","year":"2012","unstructured":"Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C, Sessa C, ESMO Guidelines Working Group. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;Suppl7:vii20\u20136.","journal-title":"Ann Oncol."},{"issue":"1","key":"1517_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000381771","volume":"81","author":"ZJ Yang","year":"2015","unstructured":"Yang ZJ, Liu ZC, Wei RJ, Li L. An analysis of prognostic factors in patients with ovarian Malignant germ cell tumors who are treated with fertility-preserving surgery. Gynecol Obstet Invest. 2015;81(1):1\u20139.","journal-title":"Gynecol Obstet Invest."},{"issue":"11","key":"1517_CR24","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.7314\/APJCP.2013.14.11.6493","volume":"14","author":"A Bilici","year":"2014","unstructured":"Bilici A, Inanc M, Ulas A, Akman T, Seker M, Babacan NA, et al. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology. Asian Pac J Cancer Prev. 2014;14(11):6493\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"1517_CR25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2013.08.028","volume":"131","author":"O Solheim","year":"2013","unstructured":"Solheim O, K\u00e6rn J, Trop\u00e9 CG, Rokkones E, Dahl AA, Nesland JM, et al. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953\u20132009). Gynecol Oncol. 2013;131(2):330\u20135.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1517_CR26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/IGC.0000000000000432","volume":"25","author":"Lopes Silva da","year":"2015","unstructured":"da Silva Lopes. J, Luiz Renna N Jr, Paulino E, de Melo AC. Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute. Int J Gynecol Cancer. 2015;25(5):786\u201391.","journal-title":"Int J Gynecol Cancer"},{"issue":"25","key":"1517_CR27","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.2014.56.3890","volume":"32","author":"DF Billmire","year":"2014","unstructured":"Billmire DF, Krailo M, Rodriguez-Galindo C, Frazier AL, et al. Reply to G. Mangili and C. Lhomm\u00e9 et al. J Clin Oncol. 2014;32(25):2816\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1517_CR28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2010.05.023","volume":"119","author":"I Ray-Coquard","year":"2010","unstructured":"Ray-Coquard I, Weber B, Lotz JP. Management of rare ovarian cancers: the experience of the French website \u201cObservatory for rare malignant tumours of the ovaries\u201d by the GINECO group: interim analysis of the first 100 patients. Gynecol Oncol. 2010;119(1):53\u20139.","journal-title":"Gynecol Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-016-1517-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1517-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T23:45:47Z","timestamp":1600559147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-016-1517-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1007\/s12094-016-1517-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}